 |
인쇄하기
취소
|
Novel wound-healing drug to go on sale
Daewoong Pharm said it signed with a licensing contract with the U.S.-based Lescarden Inc. for the exclusive distribution of Catrix, a bovine-derived complex mucopolysaccharide product, in Korea.
The unique, demonstrated ability of Catrix to expedite the development of epithelial cells makes it an ideal therapy in a variety of dermatological applications, Daewoong says.
In particular, the...
The unique, demonstrated ability of Catrix to expedite the development of epithelial cells makes it an ideal therapy in a variety of dermatological applications, Daewoong says.
In particular, the...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.